Drug profile · INN
apalutamide
ERLEADA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
apalutamide (ERLEADA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN apalutamide
Brand ERLEADA
Route ORAL
Formulation TABLET
ATC code L02BB05
Frequently asked questions
What is apalutamide?
apalutamide (ERLEADA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for apalutamide?
ERLEADA is a marketed brand name for apalutamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of apalutamide?
apalutamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.